I'd be very careful with SSRIs. This might very well turn out to be a case of the cure being worse than the disease. > If this turns out to be as interesting a

I'd be very careful with SSRIs. This might very well turn out to be a case of the cure being worse than the disease. > If this turns out to be as interesting as it sounds, well buy SSRI maker stocks Unfortunately, that suggestion on the other hand might be spot-on. Not because SSRIs truly are the cure-all they're often marketed as, but rather because manufacturers have managed to sell them as such.